IRESS LIMITED — Director's Dealing 2021

Mar 17, 2021

==> picture [82 x 63] intentionally omitted <==

The Manager Company Announcements Office Australian Stock Exchange Exchange Centre 20 Bridge Street SYDNEY NSW 2000

18 March 2021

Dear Sir or Madam

RE: APPENDIX 3Y – ANDREW WALSH – CEO & MANAGING DIRECTOR

Please find attached an Appendix 3Y announcement relating to Andrew Walsh, CEO & Managing Director.

Yours sincerely

==> picture [155 x 67] intentionally omitted <==

Peter Ferguson Chief Legal Officer & Company Secretary

Iress Limited Corporate Office: Level 16, 385 Bourke Street MELBOURNE VIC 3000 Australia ABN: 47 060 313 359

T +61 3 9018 5800 enquiries@iress.com

www.iress.com

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	Iress Limited
ABN	47 060 313 359

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Date of last notice

Andrew Walsh 4 March 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Indirect through Salernes Pty Ltd ATF Walsh Family Trust
Date of change	15 March 2021
No. of securities held prior to change	Ordinary Shares Direct: 496,980 Indirect: 129,561 626,541 Unvested Share/Rights Grants Overview: Deferred Share Rights all Series: 94,443 Performance Rights pre-2019 Series: 200,688 Unvested Rights/Grants under revised 2019 executive remuneration framework: EquityRights: 76,374

• See chapter 19 for defined terms.

15/07/2020 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

		Performance Rights: 160,936 Unvested Share/Rights Grants Details: 2017 Series Performance Rights 2017: • 4 year term, 3 year measurement period commencing 1 Jan 2018: - 54,739 • 4 year term, 4 year measurement period commencing 1 Jan 2017: - 54,739 2018 Series Deferred Shares Rights 2018: • 3 year term, granted 10 May 2018: - 51,707 Performance Rights 2018: • 4 year term, granted 10 May 2018, 3 year measurement period commencing 1 Jan 2019: - 45,605 • 4 year term, granted 10 May 2018, 4 year measurement period commencing 1 Jan 2018: - 45,605 2019 Series Deferred Shares Rights 2019: • 3 year term, granted 9 May 2019: - 42,736 2019 Series– New Framework Performance Rights 2019: • 3 year term, granted 9 May 2019: – 80,020 2020 Series– New Framework Equity Rights 2020: • 2 year term, granted 21 May 2020, 2 year measurement period commencing 28 Feb 2020 – 28 Feb 2020, (shares provided on exercise of any vested Equity Rights are subject to a mandatory 2 year holding lock (28 February 2022 – 28 February 2024): – 76,374 Performance Rights 2020: • 3 year term, granted 21 May 2020, 3 year measurement period commencing 1 Jan 2020 – 31 Dec 2022: – 80,916
Class		Ordinary
Number acquired		Ordinary Shares Direct: Nil Indirect: 7,230
Number disposed		Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		$9.38 per share

• See chapter 19 for defined terms.

15/07/2020 Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

	No. of securities held after change		Ordinary Shares Direct: Indirect: Unvested Share/Rights Grants

• See chapter 19 for defined terms.

15/07/2020 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

subject to a mandatory 2 year holding lock (28 February 2022 – 28 February 2024): – 76,374 Performance Rights 2020: • 3 year term, granted 21 May 2020, 3 year measurement period commencing 1 Jan 2020 – 31 Dec 2022: – 80,916 Nature of change Example: on-market trade, off-market trade, exercise of Granting of shares to match the value of dividends options, issue of securities under dividend reinvestment declared during the vesting period of 2019 Equity Rights. plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or No contracts detailed above traded during a +closed period where prior written clearance was required?

• See chapter 19 for defined terms.

15/07/2020 Appendix 3Y Page 4

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

15/07/2020 Appendix 3Y Page 5